{"transactions":[{"id":1021223,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":2.4288,"expiration_date":"2033-08-31","underlying":"Ordinary Shares","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1021222,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding share option became fully vested, to the extent unvested, and at the Effective Time, each share option that had an exercise price less than the ADS Consideration was automatically converted into the right to receive an amount in cash equal to the product of (i) the aggregate number of ADSs underlying such share option and (ii) the excess, if any, of (a) an amount equal to the ADS Consideration over (b) the exercise price of such share option."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.9338,"expiration_date":"2034-04-28","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1021221,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1021220,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1021219,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":72000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, each outstanding time-based restricted share unit award (\"RSU Award\"), unless agreed otherwise, became fully vested, and at the Effective Time, was automatically converted into the right to receive an amount in cash (without interest and subject to all required withholding taxes) equal to the product of (i) the aggregate number of ADSs underlying such RSU Award and (ii) the ADS Consideration."}],"balance_after":72000,"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1021218,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-08T16:30:17.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64072,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Ordinary Shares of the Issuer acquired from the Reporting Person by means of a scheme of arrangement (the \"Scheme of Arrangement\") under Part 26 of the UK Companies Act 2006, pursuant to a transaction agreement, dated as of July 8, 2025 (the \"Transaction Agreement\"), by and among the Issuer, Merck Sharp & Dohme LLC, a New Jersey limited liability company (\"Parent\") and Vol Holdings LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (\"Bidco\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Scheme of Arrangement (the \"Effective Time\"), each holder of the Scheme Shares (as defined in the Scheme of Arrangement) became entitled to receive $13.375 in cash per Scheme Share, without interest and net of any applicable withholding taxes. Because each ADS represents a beneficial ownership interest in eight (8) Ordinary Shares of the Issuer, holders of ADSs as of the Effective Time became entitled to receive eight (8) times the foregoing cash amount, or $107 in cash, without interest and net of any applicable withholding taxes, per ADS (the \"ADS Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-097941","document":"tm2528014-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925097941/tm2528014-1_4seq1.xml","form_type":"4"}},{"id":1073921,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T20:26:30.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":72000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-074396","document":"tm2522566-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925074396/tm2522566-9_4seq1.xml","form_type":"4"}},{"id":1073920,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:26:30.000Z","date":"2025-08-01","kind":"sale","planned":false,"acquired":false,"shares":1808,"price":13.1437,"value":23763.8096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the sale price of the ADSs divided by eight (8)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 64,072 Ordinary Shares represented by 8,009 ADSs."}],"balance_after":64072,"source":{"system":"sec-edgar","filing":"0001104659-25-074396","document":"tm2522566-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925074396/tm2522566-9_4seq1.xml","form_type":"4"}},{"id":1073919,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:26:30.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":65880,"source":{"system":"sec-edgar","filing":"0001104659-25-074396","document":"tm2522566-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925074396/tm2522566-9_4seq1.xml","form_type":"4"}},{"id":1144734,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2025-05-16T16:30:26.000Z","date":"2025-05-14","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":200000,"derivative":{"exercise_price":1.9338,"expiration_date":"2034-04-28","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-25-050043","document":"tm2515382-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925050043/tm2515382-1_4seq1.xml","form_type":"4"}},{"id":1144733,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T16:30:26.000Z","date":"2025-05-14","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":8.44,"value":337600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $8.3894 to $8.5688 per Ordinary Share, inclusive (or $67.115 to $68.55 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Consists of 41,880 Ordinary Shares represented by 5,235 ADSs."}],"balance_after":41880,"source":{"system":"sec-edgar","filing":"0001104659-25-050043","document":"tm2515382-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925050043/tm2515382-1_4seq1.xml","form_type":"4"}},{"id":1144732,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T16:30:26.000Z","date":"2025-05-14","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":1.9338,"value":77352.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":81880,"source":{"system":"sec-edgar","filing":"0001104659-25-050043","document":"tm2515382-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925050043/tm2515382-1_4seq1.xml","form_type":"4"}},{"id":1163750,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-04-29T17:08:29.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Share Units (\"RSUs\") covering American Depositary Shares (\"ADSs\"). Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date."}],"balance_after":96000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001104659-25-041382","document":"tm2513544-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465925041382/tm2513544-1_4seq1.xml","form_type":"4"}},{"id":1372583,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-11-07T18:56:12.000Z","date":"2024-11-06","kind":"purchase","planned":false,"acquired":true,"shares":41880,"price":4.737,"value":198385.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reported securities are represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 41,880 Ordinary Shares represented by 5,235 ADSs."}],"balance_after":41880,"source":{"system":"sec-edgar","filing":"0001104659-24-115417","document":"tm2427856-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465924115417/tm2427856-1_4seq1.xml","form_type":"4"}},{"id":1532673,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2024-04-30T16:17:12.000Z","date":"2024-04-29","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":240000,"derivative":{"exercise_price":1.9338,"expiration_date":"2034-04-28","underlying":"Ordinary Shares","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-24-054951","document":"tm2412993-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465924054951/tm2412993-3_4seq1.xml","form_type":"4"}},{"id":1788713,"issuer":{"id":74409,"kind":"organization","name":"Verona Pharma plc","symbol":"VRNA"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to Buy)","published_at":"2023-09-05T16:05:37.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to one-third of the underlying options on September 1, 2024 and the remainder in eight equal quarterly installments over the two years thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares (\"ADSs\"), each of which represents eight (8) Ordinary Shares of the Issuer."}],"balance_after":144000,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-31","underlying":"Ordinary Shares","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-23-098231","document":"tm2325478-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465923098231/tm2325478-2_4seq1.xml","form_type":"4"}},{"id":1937687,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-03-27T23:54:44.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Christina Ackermann's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Christina Ackermann's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Christina Ackermann's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Christina Ackermann's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001209191-23-021297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123021297/doc4.xml","form_type":"4"}},{"id":1937686,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-27T23:54:44.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Christina Ackermann's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":1429,"source":{"system":"sec-edgar","filing":"0001209191-23-021297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919123021297/doc4.xml","form_type":"4"}},{"id":1974588,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"Please see remarks"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2023-03-03T21:55:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":90744,"price":17.96,"value":1629762.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of stock options to purchase Common Shares under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock options will expire on the tenth anniversary of the grant date."}],"balance_after":90744,"derivative":{"exercise_price":17.96,"underlying":"Common Shares, No Par Value","underlying_shares":90744},"source":{"system":"sec-edgar","filing":"0001127602-23-008771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223008771/form4.xml","form_type":"4"}},{"id":1974587,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"Please see remarks"}}],"security":"Common Shares, No Par Value","published_at":"2023-03-03T21:55:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":28344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch + Lomb Corporation."}],"balance_after":146677,"source":{"system":"sec-edgar","filing":"0001127602-23-008771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223008771/form4.xml","form_type":"4"}},{"id":2201400,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"Please see remarks"}}],"security":"Common Shares, No Par Value","published_at":"2022-07-27T23:38:03.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch + Lomb Corporation."}],"balance_after":118333,"source":{"system":"sec-edgar","filing":"0001127602-22-019824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760222019824/form4.xml","form_type":"4"}},{"id":2243840,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T21:31:18.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of\nits stockholders, subject to the reporting person's continuous service to the issuer on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-034247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122034247/doc4.xml","form_type":"4"}},{"id":2243839,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T21:31:18.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of\nits stockholders, subject to the reporting person's continuous service to the issuer on such date."}],"balance_after":20000,"derivative":{"exercise_price":0.984,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-034247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919122034247/doc4.xml","form_type":"4"}},{"id":2278009,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Please see remarks"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2022-05-09T22:46:09.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":329670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of stock options to purchase Common Shares under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock options will expire on the tenth anniversary of the grant date."}],"balance_after":329670,"derivative":{"exercise_price":18,"underlying":"Common Shares, No Par Value","underlying_shares":329670},"source":{"system":"sec-edgar","filing":"0000899243-22-017321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017321/doc4.xml","form_type":"4"}},{"id":2278008,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Please see remarks"}}],"security":"Common Shares, No Par Value","published_at":"2022-05-09T22:46:09.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\"). Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch + Lomb Corporation (the \"Company\")."}],"balance_after":83333,"source":{"system":"sec-edgar","filing":"0000899243-22-017321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017321/doc4.xml","form_type":"4"}},{"id":2338483,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-11T21:00:43.000Z","date":"2022-03-10","kind":"tax_withholding","acquired":false,"shares":839,"price":22.56,"value":18927.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":162240,"source":{"system":"sec-edgar","filing":"0001127602-22-009006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222009006/form4.xml","form_type":"4"}},{"id":2348802,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-07T22:45:20.000Z","date":"2022-03-03","kind":"tax_withholding","acquired":false,"shares":6926,"price":23.61,"value":163522.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":163079,"source":{"system":"sec-edgar","filing":"0001127602-22-008496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222008496/form4.xml","form_type":"4"}},{"id":2362794,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-27","kind":"exercise","acquired":false,"shares":24292,"price":24.35,"value":591510.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":24.35,"expiration_date":"2022-02-27","underlying":"Common Shares, No Par Value","underlying_shares":24292},"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2362793,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":24292,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"expiration_date":"2022-02-27","underlying":"Common Shares, No Par Value","underlying_shares":24292},"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2362792,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":3006,"price":24.35,"value":73196.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs."}],"balance_after":170005,"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2362791,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":2743,"price":24.35,"value":66792.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units (\"RSUs\")."}],"balance_after":173011,"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2362790,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":10279,"price":24.35,"value":250293.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs."}],"balance_after":175754,"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2362789,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:06:49.000Z","date":"2022-02-27","kind":"exercise","acquired":true,"shares":24292,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":186033,"source":{"system":"sec-edgar","filing":"0000899243-22-008818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008818/doc4.xml","form_type":"4"}},{"id":2585862,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-08-31T20:07:22.000Z","date":"2021-08-27","kind":"tax_withholding","acquired":false,"shares":5017,"price":28.95,"value":145242.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":161741,"source":{"system":"sec-edgar","filing":"0001127602-21-024579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221024579/form4.xml","form_type":"4"}},{"id":2680501,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-04T22:30:50.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 2, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":4.07,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-038372","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919121038372/doc4.xml","form_type":"4"}},{"id":2681759,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2021-06-04T20:51:50.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":60853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":15.32,"expiration_date":"2028-03-07","underlying":"Common Shares, No Par Value","underlying_shares":60853},"source":{"system":"sec-edgar","filing":"0001127602-21-019273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221019273/form4.xml","form_type":"4"}},{"id":2681758,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2021-06-04T20:51:50.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":60345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, No Par Value","underlying_shares":60345},"source":{"system":"sec-edgar","filing":"0001127602-21-019273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221019273/form4.xml","form_type":"4"}},{"id":2681757,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-06-04T20:51:50.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":121198,"price":31.83,"value":3857732.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4.  The sales price per share reported on this Form 4 range from $31.61 to $32.11. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":166758,"source":{"system":"sec-edgar","filing":"0001127602-21-019273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221019273/form4.xml","form_type":"4"}},{"id":2681756,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-06-04T20:51:50.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":60853,"price":15.32,"value":932267.96,"ownership":{"direct":true},"balance_after":287956,"source":{"system":"sec-edgar","filing":"0001127602-21-019273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221019273/form4.xml","form_type":"4"}},{"id":2681755,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-06-04T20:51:50.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":60345,"price":14.38,"value":867761.1,"ownership":{"direct":true},"balance_after":227103,"source":{"system":"sec-edgar","filing":"0001127602-21-019273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221019273/form4.xml","form_type":"4"}},{"id":2790127,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-15T20:08:41.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":796,"price":32.82,"value":26124.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":166758,"source":{"system":"sec-edgar","filing":"0001127602-21-010592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010592/form4.xml","form_type":"4"}},{"id":2797998,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2021-03-11T01:46:40.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":8455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 13,638 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date."}],"balance_after":0,"derivative":{"expiration_date":"2021-03-07","underlying":"Common Stock","underlying_shares":8455},"source":{"system":"sec-edgar","filing":"0001127602-21-010158","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010158/form4.xml","form_type":"4"}},{"id":2797997,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T01:46:40.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":21960,"price":32.97,"value":724021.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs."}],"balance_after":167554,"source":{"system":"sec-edgar","filing":"0001127602-21-010158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010158/form4.xml","form_type":"4"}},{"id":2797996,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T01:46:40.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":25980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on March 7, 2018."}],"balance_after":189514,"source":{"system":"sec-edgar","filing":"0001127602-21-010158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010158/form4.xml","form_type":"4"}},{"id":2797995,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T01:46:40.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":8455,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on March 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":163534,"source":{"system":"sec-edgar","filing":"0001127602-21-010158","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010158/form4.xml","form_type":"4"}},{"id":2807325,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2021-03-05T22:45:54.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":52392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":52392,"derivative":{"exercise_price":32.56,"expiration_date":"2031-03-03","underlying":"Common Shares, No Par Value","underlying_shares":52392},"source":{"system":"sec-edgar","filing":"0001127602-21-009554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009554/form4.xml","form_type":"4"}},{"id":2807324,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-05T22:45:54.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":36250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc."}],"balance_after":155079,"source":{"system":"sec-edgar","filing":"0001127602-21-009554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009554/form4.xml","form_type":"4"}},{"id":2816440,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-03T21:26:33.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":5367,"price":31.42,"value":168631.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":118829,"source":{"system":"sec-edgar","filing":"0001127602-21-009134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009134/form4.xml","form_type":"4"}},{"id":3021536,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-09-28T21:37:28.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/36th of the total shares on October 24, 2020 and on each monthly anniversary thereafter such that the option shall be fully vested on September 24, 2023, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":16,"expiration_date":"2030-09-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-052238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052238/doc4.xml","form_type":"4"}},{"id":3044090,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-08-31T22:44:55.000Z","date":"2020-08-28","kind":"grant","acquired":true,"shares":28171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc."}],"balance_after":124196,"source":{"system":"sec-edgar","filing":"0001127602-20-024485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220024485/form4.xml","form_type":"4"}},{"id":3216539,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-12T00:52:13.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":4390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents matching Restricted Share Units (\"MRSUs\") granted to the Reporting Person in connection with the open market purchase of Common Shares reported on Table I above, pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the Reporting Person's continued service (except in limited circumstances)."}],"balance_after":96025,"source":{"system":"sec-edgar","filing":"0001127602-20-010317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220010317/form4.xml","form_type":"4"}},{"id":3216538,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-12T00:52:13.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":4390,"price":18.2473,"value":80105.647,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price.  This transaction was executed in multiple trades at prices ranging from 18.23 to $18.25. Information regarding the number of shares purchased and the purchase price per share will be provided upon request by the Commission staff, the Issuer or a shareholder of the Issuer."}],"balance_after":91635,"source":{"system":"sec-edgar","filing":"0001127602-20-010317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220010317/form4.xml","form_type":"4"}},{"id":3216537,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-12T00:52:13.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":3343,"price":20.96,"value":70069.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer (\"Common Shares\") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":87245,"source":{"system":"sec-edgar","filing":"0001127602-20-010317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220010317/form4.xml","form_type":"4"}},{"id":3235072,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-03T21:52:11.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":3779,"price":24.44,"value":92358.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":90588,"source":{"system":"sec-edgar","filing":"0001127602-20-009072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220009072/form4.xml","form_type":"4"}},{"id":3242177,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-02-29T00:19:07.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":81873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":81873,"derivative":{"exercise_price":24.77,"expiration_date":"2030-02-26","underlying":"Common Shares, No Par Value","underlying_shares":81873},"source":{"system":"sec-edgar","filing":"0001127602-20-008431","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008431/form4.xml","form_type":"4"}},{"id":3242176,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-02-29T00:19:07.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":19449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":94367,"source":{"system":"sec-edgar","filing":"0001127602-20-008431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008431/form4.xml","form_type":"4"}},{"id":3242175,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2020-02-29T00:16:33.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":7864,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This PSU award was previously reported on a Form 4 filed on January 10, 2017 with the maximum potential award amount of 16,384 shares. Any portion of the award not vested on February 19, 2020 was terminated as of that date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7864},"source":{"system":"sec-edgar","filing":"0001127602-20-008429","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008429/form4a.xml","form_type":"4/A","original_submission_date":"2020-02-21"}},{"id":3242174,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Shares, No Par Value","published_at":"2020-02-29T00:16:33.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":7864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on January 6, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"shares","element":"transactionShares","label":"F3","text":"This Form 4/A is being filed solely to reflect the acquisition of 7,864 Common Shares instead of the disposition of Common Shares originally reported on the Form 4 filed on February 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":55029,"source":{"system":"sec-edgar","filing":"0001127602-20-008429","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008429/form4a.xml","form_type":"4/A","original_submission_date":"2020-02-21"}},{"id":3257636,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2020-02-22T02:52:09.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":7864,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This PSU award was previously reported on a Form 4 filed on January 10, 2017 with the maximum potential award amount of 16,384 shares. Any portion of the award not vested on February 19, 2020 was terminated as of that date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7864},"source":{"system":"sec-edgar","filing":"0001127602-20-007076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007076/form4.xml","form_type":"4"}},{"id":3257635,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-22T02:52:09.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":22378,"price":26.46,"value":592121.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs."}],"balance_after":59190,"source":{"system":"sec-edgar","filing":"0001127602-20-007076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007076/form4.xml","form_type":"4"}},{"id":3257634,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-22T02:52:09.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":42267,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81568,"source":{"system":"sec-edgar","filing":"0001127602-20-007076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007076/form4.xml","form_type":"4"}},{"id":3257633,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2020-02-22T02:52:09.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":7864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on January 6, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":39301,"source":{"system":"sec-edgar","filing":"0001127602-20-007076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220007076/form4.xml","form_type":"4"}},{"id":3314755,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2020-01-09T21:17:33.000Z","date":"2020-01-07","kind":"tax_withholding","acquired":false,"shares":3360,"price":29.42,"value":98851.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":47165,"source":{"system":"sec-edgar","filing":"0001127602-20-001361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220001361/form4.xml","form_type":"4"}},{"id":3440309,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-08-13T20:03:29.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":3418,"price":22.4475,"value":76725.555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4.  The sales price per share reported on this Form 4 range from $22.30 to $22.61.\nThe reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":50525,"source":{"system":"sec-edgar","filing":"0001127602-19-026527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219026527/form4.xml","form_type":"4"}},{"id":3440308,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-08-13T20:03:29.000Z","date":"2019-08-09","kind":"tax_withholding","acquired":false,"shares":7779,"price":22.39,"value":174171.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":53943,"source":{"system":"sec-edgar","filing":"0001127602-19-026527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219026527/form4.xml","form_type":"4"}},{"id":3462108,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-07-15T20:30:55.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":3968,"price":24.81,"value":98446.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person."}],"balance_after":61722,"source":{"system":"sec-edgar","filing":"0001127602-19-024534","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219024534/form4.xml","form_type":"4"}},{"id":3600404,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-03-12T20:17:32.000Z","date":"2019-03-08","kind":"tax_withholding","acquired":false,"shares":3630,"price":23.56,"value":85522.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":65690,"source":{"system":"sec-edgar","filing":"0001127602-19-011019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219011019/form4.xml","form_type":"4"}},{"id":3624653,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2019-03-01T21:57:56.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":62004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":62004,"derivative":{"exercise_price":23.16,"expiration_date":"2029-02-27","underlying":"Common Shares, No Par Value","underlying_shares":62004},"source":{"system":"sec-edgar","filing":"0001127602-19-009227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009227/form4.xml","form_type":"4"}},{"id":3624652,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-03-01T21:57:56.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":21310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":69320,"source":{"system":"sec-edgar","filing":"0001127602-19-009227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009227/form4.xml","form_type":"4"}},{"id":3698545,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2019-01-10T21:02:46.000Z","date":"2019-01-08","kind":"tax_withholding","acquired":false,"shares":3446,"price":21.25,"value":73227.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":48010,"source":{"system":"sec-edgar","filing":"0001127602-19-001759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219001759/form4.xml","form_type":"4"}},{"id":3789319,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2018-10-17T20:15:28.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":4542,"price":25.5,"value":115821.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":51456,"source":{"system":"sec-edgar","filing":"0001127602-18-030504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218030504/form4.xml","form_type":"4"}},{"id":3789318,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2018-10-17T20:15:28.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":15404,"price":24.83,"value":382481.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":55998,"source":{"system":"sec-edgar","filing":"0001127602-18-030504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218030504/form4.xml","form_type":"4"}},{"id":3846552,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2018-08-13T21:04:16.000Z","date":"2018-08-09","kind":"tax_withholding","acquired":false,"shares":7779,"price":23.52,"value":182962.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":71402,"source":{"system":"sec-edgar","filing":"0001127602-18-025213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218025213/form4.xml","form_type":"4"}},{"id":4004287,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Restricted Share Units","published_at":"2018-03-10T01:54:09.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":13638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 6,819 and the maximum number that can be distributed is 13,638. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured for the 20 trading days preceding the TSR Measurement Date (\"Measurement Date\") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 6,819 and the maximum number that can be distributed is 13,638. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured for the 20 trading days preceding the TSR Measurement Date (\"Measurement Date\") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."}],"balance_after":13638,"derivative":{"expiration_date":"2021-03-07","underlying":"Common Stock","underlying_shares":13638},"source":{"system":"sec-edgar","filing":"0001127602-18-011037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011037/form4.xml","form_type":"4"}},{"id":4004286,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2018-03-10T01:54:09.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":60853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":60853,"derivative":{"exercise_price":15.32,"expiration_date":"2028-03-07","underlying":"Common Shares, No Par Value","underlying_shares":60853},"source":{"system":"sec-edgar","filing":"0001127602-18-011037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011037/form4.xml","form_type":"4"}},{"id":4004285,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2018-03-10T01:54:09.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":20457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Valeant Pharmaceuticals International, Inc. (\"Valeant\")."}],"balance_after":79181,"source":{"system":"sec-edgar","filing":"0001127602-18-011037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011037/form4.xml","form_type":"4"}},{"id":4103588,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2018-01-09T20:25:17.000Z","date":"2018-01-08","kind":"tax_withholding","acquired":false,"shares":3649,"price":23.85,"value":87028.65,"ownership":{"direct":true},"balance_after":58724,"source":{"system":"sec-edgar","filing":"0001127602-18-001433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218001433/form4.xml","form_type":"4"}},{"id":4237060,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"officer":true,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Common Stock, No Par Value","published_at":"2017-08-11T20:41:02.000Z","date":"2017-08-09","kind":"tax_withholding","acquired":false,"shares":6046,"price":15.37,"value":92927.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":62373,"source":{"system":"sec-edgar","filing":"0001127602-17-025507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760217025507/form4.xml","form_type":"4"}},{"id":4406654,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2017-03-03T22:32:29.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":60345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":60345,"derivative":{"exercise_price":14.38,"expiration_date":"2027-03-01","underlying":"Common Shares, no par value","underlying_shares":60345},"source":{"system":"sec-edgar","filing":"0001681871-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000168187117000006/primary_doc.xml","form_type":"4"}},{"id":4494393,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Restricted Share Units","published_at":"2017-01-11T00:01:50.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":16384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents a grant of performance-based RSUs.  The target number of performance-based RSUs granted to the reporting person was 8,192 and the maximum number that can be distributed is 16,384.  The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured on January 6, 2020 (the \"Measurement Date\").  If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a grant of performance-based RSUs.  The target number of performance-based RSUs granted to the reporting person was 8,192 and the maximum number that can be distributed is 16,384.  The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured on January 6, 2020 (the \"Measurement Date\").  If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."}],"balance_after":16384,"derivative":{"expiration_date":"2020-01-06","underlying":"Common Stock","underlying_shares":16384},"source":{"system":"sec-edgar","filing":"0001681871-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000168187117000004/primary_doc.xml","form_type":"4"}},{"id":4494392,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":74410,"kind":"person","name":"ACKERMANN CHRISTINA","position":1,"cik":"0001681871","reported_name":"ACKERMANN CHRISTINA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock, no par value","published_at":"2017-01-11T00:01:50.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":24575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of Restricted Share Units (\"RSUs\") which will vest one-third on each of the three anniversaries following the date of grant, subject to the reporting person's continued service subject to continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Valeant Pharmaceuticals International, Inc. (\"Valeant\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total number of shares excludes the 78,918 performance-vesting RSUs previously included in Column 5 of the reporting person's Form 4 filed on August 10, 2016, the target number of which granted to the reporting person was 26,306 and the maximum number of which that can be distributed is 78,918."}],"balance_after":68419,"source":{"system":"sec-edgar","filing":"0001681871-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000168187117000004/primary_doc.xml","form_type":"4"}}]}